BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 18268402)

  • 1. The noncompetitive antagonism of histamine H1 receptors expressed in Chinese hamster ovary cells by olopatadine hydrochloride: its potency and molecular mechanism.
    Matsumoto Y; Funahashi J; Mori K; Hayashi K; Yano H
    Pharmacology; 2008; 81(3):266-74. PubMed ID: 18268402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the ocular antiallergic and antihistaminic effects of olopatadine (AL-4943A), a novel drug for treating ocular allergic diseases.
    Sharif NA; Xu SX; Miller ST; Gamache DA; Yanni JM
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1252-61. PubMed ID: 8819509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olopatadine suppresses the migration of THP-1 monocytes induced by S100A12 protein.
    Kishimoto K; Kaneko S; Ohmori K; Tamura T; Hasegawa K
    Mediators Inflamm; 2006; 2006(1):42726. PubMed ID: 16864903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral histamine H1 receptor binding potential measured with PET under a test dose of olopatadine, an antihistamine, is reduced after repeated administration of olopatadine.
    Senda M; Kubo N; Adachi K; Ikari Y; Matsumoto K; Shimizu K; Tominaga H
    J Nucl Med; 2009 Jun; 50(6):887-92. PubMed ID: 19443589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of olopatadine and other histamine H1 receptor antagonists on the skin inflammation induced by repeated topical application of oxazolone in mice.
    Tamura T; Masaki S; Ohmori K; Karasawa A
    Pharmacology; 2005 Dec; 75(1):45-52. PubMed ID: 15942272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand-specific contribution of the N terminus and E2-loop to pharmacological properties of the histamine H1-receptor.
    Strasser A; Wittmann HJ; Seifert R
    J Pharmacol Exp Ther; 2008 Sep; 326(3):783-91. PubMed ID: 18577700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of olopatadine hydrochloride, an anti-histamine drug, on rhinitis induced by intranasal instillation of toluene-2,4-diisocyanate in rats.
    Tamura T; Komai M
    Int Immunopharmacol; 2008 Jun; 8(6):916-21. PubMed ID: 18442798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of olopatadine hydrochloride on the number of scratching induced by repeated application of oxazolone in mice.
    Tamura T; Amano T; Ohmori K; Manabe H
    Eur J Pharmacol; 2005 Nov; 524(1-3):149-54. PubMed ID: 16259975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of Lys191 and Lys179 in regulating thermodynamic binding forces of ligands to determine their binding affinity for human histamine H
    Kobayashi C; Tanaka A; Yasuda T; Hishinuma S
    Biochem Pharmacol; 2020 Oct; 180():114185. PubMed ID: 32738199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical characterization of desloratadine, a potent antagonist of the human histamine H(1) receptor.
    Anthes JC; Gilchrest H; Richard C; Eckel S; Hesk D; West RE; Williams SM; Greenfeder S; Billah M; Kreutner W; Egan RE
    Eur J Pharmacol; 2002 Aug; 449(3):229-37. PubMed ID: 12167464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain histamine H receptor occupancy of orally administered antihistamines measured by positron emission tomography with (11)C-doxepin in a placebo-controlled crossover study design in healthy subjects: a comparison of olopatadine and ketotifen.
    Tashiro M; Mochizuki H; Sakurada Y; Ishii K; Oda K; Kimura Y; Sasaki T; Ishiwata K; Yanai K
    Br J Clin Pharmacol; 2006 Jan; 61(1):16-26. PubMed ID: 16390347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological and functional characterisation of the wild-type and site-directed mutants of the human H1 histamine receptor stably expressed in CHO cells.
    Moguilevsky N; Varsalona F; Guillaume JP; Noyer M; Gillard M; Daliers J; Henichart JP; Bollen A
    J Recept Signal Transduct Res; 1995; 15(1-4):91-102. PubMed ID: 8903934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of olopatadine and selected antihistamines with model and natural membranes.
    Brockman HL; Momsen MM; Knudtson JR; Miller ST; Graff G; Yanni JM
    Ocul Immunol Inflamm; 2003 Dec; 11(4):247-68. PubMed ID: 14704897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of impromidine- and arpromidine-derived guanidines on recombinant human and guinea pig histamine H1 and H2 receptors.
    Xie SX; Schalkhausser F; Ye QZ; Seifert R; Buschauer A
    Arch Pharm (Weinheim); 2007 Jan; 340(1):9-16. PubMed ID: 17206612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unique binding pocket for KW-4679 in the histamine H1 receptor.
    Nonaka H; Otaki S; Ohshima E; Kono M; Kase H; Ohta K; Fukui H; Ichimura M
    Eur J Pharmacol; 1998 Mar; 345(1):111-7. PubMed ID: 9593602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis for the selective interaction of synthetic agonists with the human histamine H1-receptor compared with the guinea pig H1-receptor.
    Strasser A; Wittmann HJ; Kunze M; Elz S; Seifert R
    Mol Pharmacol; 2009 Mar; 75(3):454-65. PubMed ID: 19047480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in pH differently affect the binding properties of histamine H1 receptor antagonists.
    Gillard M; Chatelain P
    Eur J Pharmacol; 2006 Jan; 530(3):205-14. PubMed ID: 16388798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olopatadine (AL-4943A): ligand binding and functional studies on a novel, long acting H1-selective histamine antagonist and anti-allergic agent for use in allergic conjunctivitis.
    Sharif NA; Xu SX; Yanni JM
    J Ocul Pharmacol Ther; 1996; 12(4):401-7. PubMed ID: 8951676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential thermodynamic driving force of first- and second-generation antihistamines to determine their binding affinity for human H1 receptors.
    Hishinuma S; Sugawara K; Uesawa Y; Fukui H; Shoji M
    Biochem Pharmacol; 2014 Sep; 91(2):231-41. PubMed ID: 25065879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N1-(3-cyclohexylbutanoyl)-N2-[3-(1H-imidazol-4-yl)propyl]guanidine (UR-AK57), a potent partial agonist for the human histamine H1- and H2-receptors.
    Xie SX; Kraus A; Ghorai P; Ye QZ; Elz S; Buschauer A; Seifert R
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1262-8. PubMed ID: 16554355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.